When SciSafe announced the expansion of its biorepository network with a new facility in East Brunswick, it marked more than just another victory for the state’s thriving life sciences sector; highlighted New Jersey’s growing role as a cold storage powerhouse.
The facility, which adds five million cubic feet of capacity and hundreds of new cryogenic and ultra-low freezers, recognizes growing demand for temperature-controlled storage driven by biopharmaceutical innovation, healthcare logistics and proximity to one of the nation’s busiest transportation corridors.
For SciSafe, the decision to expand in New Jersey was strategic. The new site offers same-day cold chain fulfillment and is located near I-95 and Newark Liberty International Airport, allowing for rapid, compliant movement of sensitive biologics and pharmaceuticals.
The facility’s Good Manufacturing Practice (GMP) compliant infrastructure, advanced inventory visibility systems, and rigorous temperature monitoring protocols position it to support cutting-edge therapies such as cellular and genetic treatments. Sectors that depend on storage precision measured in fractions of a degree.
While SciSafe’s announcement grabbed the headlines, it is part of a much larger trend. The Garden State is quickly becoming one of the most competitive markets for cold storage development in the U.S., driven by its combination of scientific expertise, logistical advantages and sustained industrial investment. According to Cushman & Wakefield’s Exploring the Future of Cold Storage report, rising consumer expectations, the growth of grocery e-commerce, and the globalization of pharmaceutical supply chains are driving unprecedented demand for refrigerated and frozen storage.
Nationally, vacancy rates remain tight and, in many cases, new refrigeration facilities are pre-leased before construction even begins.
Nowhere is this transformation more visible than in New Jersey. The state benefits from what Cushman & Wakefield describes as the “Three Ps” in cold storage site selection: population, production and ports.
With more than nine million residents and proximity to tens of millions more in the New York and Philadelphia metropolitan areas, New Jersey offers direct access to dense consumer markets. It is also home to a strong base of biopharmaceutical and life sciences companies, which have long relied on validated cold chain infrastructure for R&D and clinical trials. And perhaps most importantly, it is located within a logistics network anchored in the port of New York and New Jersey, one of the largest and busiest on the East Coast.
Port Authority data shows the scale of this gateway: More than 7.8 million loaded containers passed through its terminals in 2023, a large portion of which carried perishable or temperature-sensitive cargo.
These volumes create a natural demand for nearby cold storage facilities that can efficiently handle cross-dock operations and maintain temperature integrity during multimodal transitions. New developments are clustering around industrial zones adjacent to ports and major transportation arteries, shortening transfer times and improving energy efficiency.
The life sciences ecosystem has played a critical role in sustaining this growth. BioNJ, the state’s life sciences trade association, has advocated for policies and infrastructure that support biopharmaceutical expansion, from advanced manufacturing to AI-driven drug development. Their initiatives highlight the need for digital, data and logistics resources that enable innovation, a framework that naturally extends to validated cold storage as a critical capability.
Still, increasing demand for cold storage presents challenges. The sector is energy and capital intensive, and requires facilities with high power capacity, specialized insulation and backup systems capable of maintaining constant temperature stability. According to Cushman & Wakefield analysis, a modern 200,000-square-foot cold storage facility can require several megawatts of power, putting its energy footprint on par with light manufacturing operations.
Limited land availability and complex zoning add additional limitations, particularly in suburban industrial corridors. These barriers are driving developers to retrofit older facilities or seek vertical warehouse designs that maximize efficiency within existing space.
As New Jersey’s cold storage footprint grows, so does the need for specialized talent, from quality assurance professionals and temperature mapping technicians to logistics planners trained in cold chain validation. State agencies and educational institutions are beginning to respond with training programs aimed at building this pool of expertise, ensuring that the region’s labor market evolves along with its infrastructure.
In many ways, the rise of cold storage in New Jersey represents the convergence of two of its greatest strengths: logistics and life sciences. The state’s port and highway infrastructure make it a natural distribution hub, while its research institutions and biopharmaceutical base ensure constant demand for temperature-controlled capacity. SciSafe’s expansion captures that intersection perfectly: a facility designed to handle today’s pharmaceutical storage needs while anticipating tomorrow’s scale challenges.
The post Why New Jersey’s Increased Cold Storage Matters for Logistics appeared first on FreightWaves.
Source link
